Table 1.
Clinicopathologic features | n | miR-302c-3p expression | P | ||
---|---|---|---|---|---|
Low level (n=40) | High level (n=40) | ||||
Age (year) | ≤50 | 32 | 14 | 18 | 0.361 |
>50 | 48 | 26 | 22 | ||
Sex | Male | 64 | 30 | 34 | 0.264 |
Female | 16 | 10 | 6 | ||
HBV infection | No | 17 | 6 | 9 | 0.390 |
Yes | 63 | 34 | 31 | ||
Serum AFP level (ng/mL) | ≤20 | 22 | 8 | 14 | 0.133 |
>20 | 58 | 32 | 26 | ||
Tumor size (cm) | ≤5 | 20 | 8 | 12 | 0.302 |
>5 | 60 | 32 | 28 | ||
No. of tumor nodules | 1 | 68 | 30 | 38 | 0.012* |
≥2 | 12 | 10 | 2 | ||
Cirrhosis | Absent | 28 | 16 | 12 | 0.348 |
Present | 52 | 24 | 28 | ||
Venous infiltration | Absent | 40 | 15 | 25 | 0.025* |
Present | 40 | 25 | 15 | ||
Edmondson-Steiner grading | I+II | 60 | 28 | 32 | 0.302 |
III+IV | 20 | 12 | 8 | ||
TNM tumor stage | I+II | 64 | 27 | 37 | 0.005* |
III+IV | 16 | 13 | 3 |
HBV, hepatitis B virus; AFP, alpha-fetoprotein; TNM, tumor-node-metastasis. *Statistically significant.